Using FDG PET/CT for assessment of idiopathic pulmonary fibrosis disease activity and prediction of prognosis

<bold>Background:</bold> Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. Although the overall prognosis is poor, the clinical course varies. Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a valuable tool capable of assessing inflammation, infection, and malignancy. Some studies suggested that FDG PET scans may be helpful in the evaluation of IPF and changes in response after therapy. <bold>Objective:</bold> Our primary objective is to assess the usefulness of FDG PET/computed tomography(CT) in diagnosing and differential diagnosis of IPF. Then, we used FDG PET to assess disease activity and severity, before and after treatment. Finally, no definite prognostic indicator was defined in IPF, so we evaluated the prognostic value of FDG PET in IPF. <bold>Results:</bold> We had included 71 patients (67.2±19.7 years-old, 79% men). After a mean follow-up of 26 months, 27 patients died. In visual analysis, hypermetabolism was found mostly at peripheral and basal portions of bilateral lungs, which was compatible with change of morphology on CT. Our initial findings, analyzed using Kaplan-Meier methodology, indicated a cutoff value for the average of SUVmean at 0.99. This resulted in a borderline difference in all-cause mortality (p=0.065). These preliminary results suggest a potential association between FDG PET/CT findings and mortality in IPF. <bold>Conclusions:</bold> FDG PET has potential in predicting survival in IPF. Further patient enrollment and further analysis would be needed. <table-wrap><object-id>erj;64/suppl_68/PA1643/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td>Death</td><td>Survived</td></tr><tr><td>Age</td><td>66</td><td>68</td></tr><tr><td>Survival(months)</td><td>20±17</td><td>30±22</td></tr><tr><td>Early SUVmean</td><td>0.99±0.33</td><td>1.09±0.34</td></tr><tr><td>Delayed SUVmean</td><td>0.99±0.41</td><td>1.03±0.33</td></tr></tbody></table></table-wrap>

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa1643
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using FDG PET/CT for assessment of idiopathic pulmonary fibrosis disease activity and prediction of prognosis

Chun‐Kai Huang, Jei‐Yie Huang
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Using FDG PET/CT for assessment of idiopathic pulmonary fibrosis disease activity and prediction of prognosis

Chun‐Kai Huang, Jei‐Yie Huang
article en

Abstract

<bold>Background:</bold> Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause. Although the overall prognosis is poor, the clinical course varies. Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a valuable tool capable of assessing inflammation, infection, and malignancy. Some studies suggested that FDG PET scans may be helpful in the evaluation of IPF and changes in response after therapy. <bold>Objective:</bold> Our primary objective is to assess the usefulness of FDG PET/computed tomography(CT) in diagnosing and differential diagnosis of IPF. Then, we used FDG PET to assess disease activity and severity, before and after treatment. Finally, no definite prognostic indicator was defined in IPF, so we evaluated the prognostic value of FDG PET in IPF. <bold>Results:</bold> We had included 71 patients (67.2±19.7 years-old, 79% men). After a mean follow-up of 26 months, 27 patients died. In visual analysis, hypermetabolism was found mostly at peripheral and basal portions of bilateral lungs, which was compatible with change of morphology on CT. Our initial findings, analyzed using Kaplan-Meier methodology, indicated a cutoff value for the average of SUVmean at 0.99. This resulted in a borderline difference in all-cause mortality (p=0.065). These preliminary results suggest a potential association between FDG PET/CT findings and mortality in IPF. <bold>Conclusions:</bold> FDG PET has potential in predicting survival in IPF. Further patient enrollment and further analysis would be needed. <table-wrap><object-id>erj;64/suppl_68/PA1643/TB1</object-id><object-id>T1</object-id><object-id>TB1</object-id><table><colgroup><col></col><col></col><col></col></colgroup><tbody><tr><td></td><td>Death</td><td>Survived</td></tr><tr><td>Age</td><td>66</td><td>68</td></tr><tr><td>Survival(months)</td><td>20±17</td><td>30±22</td></tr><tr><td>Early SUVmean</td><td>0.99±0.33</td><td>1.09±0.34</td></tr><tr><td>Delayed SUVmean</td><td>0.99±0.41</td><td>1.03±0.33</td></tr></tbody></table></table-wrap>

National Taiwan University Hospital (TW)
Good health and well-being
Openalex Percentile: Top 63%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Using FDG PET/CT for assessment of idiopathic pulmonary fibrosis disease activity and prediction of prognosis — Chun‐Kai Huang, Jei‐Yie Huang · (2024) | TGRS Research Map | TGRS